Abstract
Cutaneous fungal infections are frequently associated with an inflammatory component including irritated skin, itching and stinging/burning. Therapeutic anti-fungal agents that have anti-inflammatory activity have the potential to provide clinical benefit beyond fungus eradication. Recently, certain anti-fungal agents have been shown to have intrinsic anti-inflammatory activity, therefore we sought to determine the extent of the anti-inflammatory activity of these compounds. The anti-inflammatory activities of eight anti-fungal agents (butoconazole, ciclopirox olamine, fluconazole, miconazole nitrate, sertaconazole nitrate, terconazole, tioconazole and ketoconazole) were compared in a number of preclinical models of dermal inflammation and pruritus. While butoconazole, ciclopirox olamine, fluconazole, and miconazole nitrate were all found to have anti-inflammatory activity, only sertaconazole nitrate reduced the release of cytokines from activated lymphocytes and mitigated inflammation in animal models of irritant contact dermatitis and neurogenic inflammation. In addition, sertaconazole nitrate inhibited contact hypersensitivity and scratching responses in a murine model of pruritus. Furthermore, the in vitro and in vivo anti-inflammatory activity of sertaconazole nitrate was found to be greater than other topical anti-fungal agents examined. These studies demonstrate that topical administration of clinically relevant concentrations of sertaconazole nitrate resulted in an efficacious anti-inflammatory activity against a broad spectrum of dermal inflammation models and itch. The anti-inflammatory properties of sertaconazole may contribute to the efficacy of the drug in the treatment of cutaneous fungal conditions and provide greater anti-inflammatory activity compared with other anti-fungal agents.
Similar content being viewed by others
Abbreviations
- PHA:
-
Phytohemagglutinin
- PBMC:
-
Peripheral blood mononuclear cells
- RTX:
-
Resiniferatoxin
- TPA:
-
Tetradecanoyl phorbol acetate
- TNFα:
-
Tumor necrosis factor-α
- IL-2:
-
Interleukin-2
- IFNγ:
-
Interferon γ
- IL-4:
-
Interleukin-4
- GM-CSF:
-
Granulocyte macrophage colony-stimulating factor
References
Agut J, Tarrida N, Sacristan A, Ortiz JA (1996) Antiinflammatory activity of topically applied sertaconazole nitrate. Meth Find Exp Clin Pharmacol 18:233–234
Al Hasan M, Fitzgerald SM, Saoudian M, Krishnaswanmy G (2004) Dermatology for the practicing allergist: tinea pedis and its complications. Clin Mol Allergy 2:5
Anderson MR, Klink K, Cohrssen A (2004) Evaluation of vaginal complaints. JAMA 291:1368–1379
Andoh T, Kuraishi Y (2003) Nitric oxide enhances substance P-induced itch-associated responses in mice. Br J Pharmacol 138:202–208
Aste N, Pau M, Aste N, Biggio P (2003) Tinea pedis observed in Cagliari, Italy, between 1996 and 2000. Mycoses 46:38–41
Barkey WF (1987) Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream). J Am Acad Dermatol 17:518–519
Bernhard JD (1994) Scratching. In: Bernhard JD (ed) Itch mechanisms and management of pruritus. McGraw-Hill, New York, pp 90–103
Carrillo-Munoz AJ, Fernandez-Torres B, Guarro J (2003) In vitro antifungal activity of sertaconazole against 309 dermatophyte clinical isolates. J Chemother 15:555–557
Carrillo-Munoz AJ, Guglietta A, Palacin C et al (2004) In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Chemotherapy 50:308–313
Cohen AD, Wolak A, Alkan M, Shalev R, Vardy DA (2002) AFSS: athlete’s foot severity score. A proposal and validation. Mycoses 45:97–100
De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10:133–139
Engeman T, Gorbachev AV, Kish DD, Fairchild RL (2004) The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol 76:941–949
Erbagci Z (2004) Topical therapy for dermatophytoses: should corticosteroids be included? Am J Clin Dermatol 5:375–384
Friccius H, Pohla H, Adibzadeh M, Siegels-Hubenthal P, Schenk A, Pawelec G (1992) The effects of the anti-fungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells. Int J Immunopharmacol 14:791–799
Holzer P (1998) Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30:5–11
Koga T, Ishizaki H, Matsumoto T, Hori Y (1993) Cytokine production of peripheral blood mononuclear cells in a dermatophytosis patient in response to stimulation with trichophytin. J Dermatol 20:441–443
Koga T, Shimizu A, Nakayama J (2001) Interferon-gamma production in peripheral lymphocytes of patients with tinea pedis: comparison of patients with and without tinea unguium. Med Mycol 39:87–90
Kuraishi Y, Nagasawa T, Hayashi K, Satoh M (1995) Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 275:229–233
Levitz SM (1992) Overview of host defenses in fungal infections. Clin Infect Dis Suppl 1:S37–S42
Linhares IM, Witkin SS, Miranda SD et al (2001) Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Infect Dis Obstet Gynecol 9:221–225
Merlos M, Vericat ML, Garcia-Rafanell J, Forn J (1996) Topical anti-inflammatory properties of flutrimazole, a new imidazole anti-fungal agent. Inflamm Res 45:20–25
Mertens RL, Morias J, Verhamme G (1976) A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections. Dermatologica 153:228–235
Moss RB, Moll T, El-Kalay M et al (2004) Th1/Th2 cells in inflammatory disease states: therapeutic implications. Expert Opin Biol Ther 4:1887–1896
Nakajima H (2005) The pathophysiology and defense mechanism against superficial and subcutaneous fungal infection. Nippon Ishinkin Gakkai Zasshi 46:5–9
Nakamura Y, Kano R, Hasegawa A, Watanabe S (2002) Interleukin-8 and tumor necrosis factor alpha production in human epidermal keratinocytes induced by Trichophyton mentagrophytes. Clin Diagn Lab Immunol 9:935–937
Palacin C, Tarrago C, Ortiz JA (2000) Sertaconazole: pharmacology of a gynecological antifungal agent. Int J Gynaecol Obstet 71(Suppl 1):S37–S46
Rao TS, Currie JL, Shaffer AF, Isakson PC (1993) Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17:723–741
Richardson JD, Vasko MR (2002) Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302:839–845
Schmelz M, Handwerker HO (2003) Neurophysiologic basis of itch. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F (eds) Itch basic mechanisms and therapy. Marcel Dekker, New York, pp 5–20
Slunt JB, Taketomi EA, Woodfolk JA, Hayden ML, Platts-Mills TA (1996) The immune responses to Trichophyton tonsurans: distinct T cell cytokine profiles to a single protein among subjects with immediate and delayed hypersensitivity. J Immunol 157:5192–5197
Steinhilber D, Jaschonek K, Knospe J, Morof O, Roth HJ (1990) Effects of novel anti-fungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway. Arzneimittelforschung 40:1260–1263
Szallasi A, Blumberg PM (1989) Neurogenic component of phorbol ester-induced mouse skin inflammation. Cancer Res 49:6052–6057
Torres J, Marquez M, Camps F (2000) Sertaconazole in the treatment of mycoses: from dermatology to gynecology. Int J Gynaecol Obstet 71(Suppl 1):S3-S20
Van Wauwe J, Aerts F, Walter H, de Boer M (1995) Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors. Inflamm Res 44:400–405
Weinstein A, Berman B (2002) Topical treatment of common superficial tinea infections. Am Fam Physician 65:2095–2102
Woodfolk JA, Platts-Mills TA (2001) Diversity of the human allergen-specific T cell repertoire associated with distinct skin test reactions: delayed-type hypersensitivity-associated major epitopes induced Th1- and Th2-dominated responses. J Immunol 167:5412–5419
Wortzel MH (1982) A double-blind study comparing the superiority of a combination anti-fungal (clotrimazole)/steroidal (betamethasone dipropionate) product. Cutis 30:258–261
Yosipovitch G, Greaves MW (2003) Definitions of itch. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F (eds) Itch basic mechanisms and therapy. Marcel Dekker, New York, pp 1–4
Young JM, De Young LM (1989) Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents. In: Chang JY, Lewis JA (eds) Pharmacol methods control inflammation. Alan R Liss Inc, New York, pp 215–231
Zhang L, Tinkle SS (2000) Chemical activation of innate and specific immunity in contact dermatitis. J Invest Dermatol 115:168–176
Acknowledgments
The authors are grateful to Dr. Jeffrey Travers for discussions of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liebel, F., Lyte, P., Garay, M. et al. Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res 298, 191–199 (2006). https://doi.org/10.1007/s00403-006-0679-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-006-0679-8